Wednesday, 7 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange

Zenith Drugs Ltd

NSE: ZENITHDRUG · Pharmaceuticals & Biotechnology · 21 announcements

Share price
₹42.15
Market cap
₹72.28 Cr
Revenue (annual)
₹171.2 Cr
Net profit (annual)
₹3.94 Cr
P/E (TTM)
18.3×Sector 47.4×
Promoter holding
69.98%
FII holding
0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

13:00 IST NSE
Other Announcement

Zenith Drugs Other Announcement

Zenith Drugs Limited submitted its Structured Digital Database compliance certificate for the financial year 2026. This confirms adherence to SEBI insider trading monitoring regulations.

11:52 IST NSE
Other Announcement

Zenith Drugs Other Announcement

Promoters of Zenith Drugs Limited submitted an annual declaration for FY 2025-26 under SEBI Takeover Regulations. The filing confirms that the promoter group and persons acting in concert did not create any encumbrances or pledges on their shareholding during the year. This is a routine regulatory compliance disclosure.